Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Home
Sebnem Pırıldar, MD: A Preliminary Open-Label Study of Moclobemide Treatment of Pain Disorder
Sebnem Pırıldar, MD: A Preliminary Open-Label Study of Moclobemide Treatment of Pain Disorder
$
30.00
Sebnem Pırıldar, MD: A Preliminary Open-Label Study of Moclobemide Treatment of Pain Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 3 Articles
Tags:
berna-zileli
,
hayriye-elbi
,
maoi
,
meltem-uyar
,
moclobemide
,
pain
,
rima
,
sebnem-pirildar
,
somatoform-disorders
,
ülkü-sezgin
Description
Description
Sebnem Pırıldar, MD
GENERAL PSYCHOPHARMACOLOGY
A Preliminary Open-Label Study of Moclobemide Treatment of Pain Disorder
Sebnem Pırıldar, MD, Ülkü Sezgin, MD, Hayriye Elbi, MD, Meltem Uyar, MD, and Berna Zileli, MD
Related products
Intravenous Magnesium for the Management of Chronic Pain: An Updated Review of the Literature
$
30.00
Add to cart
Details
Andrea de Bartolomeis, MD, PhD: The Homer Family and the Signal Transduction System at Glutamatergic Postsynaptic Density: Potential Role in Behavior and Pharmacotherapy
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression
$
30.00
Add to cart
Details
Page load link
Go to Top